Plasma proenkephalin A 119159 and dipeptidyl peptidase 3 on confirmation after heart failure help anticipate long haul neurological result

A large proportion of adult survivors of cardiac arrest have a poor neurological outcome. Guidelines recommend multimodal neuro-prognostication no earlier than 72–96�?�h after cardiac arrest. There is great interest in earlier prognostic markers, including very early markers at admission. The novel blood biomarkers proenkephalin A 119–159 (penKid), bioactive adrenomedullin (bio-ADM) and circulating dipeptidyl peptidase 3 (cDPP3) have not been previously investigated for the early prognosis of cardiac arrest survivors.

Author(s): Bergthóra Thorgeirsdóttir Lund University, Sweden

Abstract | PDF

Share This Article